nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0352	0.0655	CbGbCtD
Asenapine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0331	0.0616	CbGbCtD
Asenapine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0331	0.0616	CbGbCtD
Asenapine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0299	0.0557	CbGbCtD
Asenapine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.029	0.0539	CbGbCtD
Asenapine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0273	0.0507	CbGbCtD
Asenapine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0273	0.0507	CbGbCtD
Asenapine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0251	0.0467	CbGbCtD
Asenapine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0247	0.0459	CbGbCtD
Asenapine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0247	0.0459	CbGbCtD
Asenapine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0227	0.0422	CbGbCtD
Asenapine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0213	0.0396	CbGbCtD
Asenapine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0207	0.0384	CbGbCtD
Asenapine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0187	0.0348	CbGbCtD
Asenapine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0187	0.0348	CbGbCtD
Asenapine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0184	0.0343	CbGbCtD
Asenapine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0173	0.0323	CbGbCtD
Asenapine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0173	0.0323	CbGbCtD
Asenapine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0157	0.0292	CbGbCtD
Asenapine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0157	0.0292	CbGbCtD
Asenapine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0135	0.0252	CbGbCtD
Asenapine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0131	0.0244	CbGbCtD
Asenapine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0119	0.0221	CbGbCtD
Asenapine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0119	0.0221	CbGbCtD
Asenapine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0114	0.0212	CbGbCtD
Asenapine—UGT1A4—blood plasma—acquired immunodeficiency syndrome	0.00407	0.048	CbGeAlD
Asenapine—DRD1—nerve—acquired immunodeficiency syndrome	0.00274	0.0324	CbGeAlD
Asenapine—HTR5A—nervous system—acquired immunodeficiency syndrome	0.00248	0.0292	CbGeAlD
Asenapine—HTR5A—central nervous system—acquired immunodeficiency syndrome	0.00239	0.0281	CbGeAlD
Asenapine—HTR5A—brain—acquired immunodeficiency syndrome	0.00189	0.0223	CbGeAlD
Asenapine—HTR7—nerve—acquired immunodeficiency syndrome	0.00172	0.0202	CbGeAlD
Asenapine—DRD2—nerve—acquired immunodeficiency syndrome	0.00162	0.0191	CbGeAlD
Asenapine—UGT1A4—digestive system—acquired immunodeficiency syndrome	0.00156	0.0184	CbGeAlD
Asenapine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00153	0.018	CbGeAlD
Asenapine—UGT1A4—blood—acquired immunodeficiency syndrome	0.00149	0.0176	CbGeAlD
Asenapine—HTR7—endothelium—acquired immunodeficiency syndrome	0.00146	0.0172	CbGeAlD
Asenapine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00136	0.016	CbGeAlD
Asenapine—HTR7—blood plasma—acquired immunodeficiency syndrome	0.0013	0.0153	CbGeAlD
Asenapine—HRH2—skin of body—acquired immunodeficiency syndrome	0.00123	0.0145	CbGeAlD
Asenapine—HTR2A—nerve—acquired immunodeficiency syndrome	0.00107	0.0126	CbGeAlD
Asenapine—HTR1E—nervous system—acquired immunodeficiency syndrome	0.00106	0.0125	CbGeAlD
Asenapine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00103	0.0122	CbGeAlD
Asenapine—HTR1E—central nervous system—acquired immunodeficiency syndrome	0.00102	0.012	CbGeAlD
Asenapine—HRH2—digestive system—acquired immunodeficiency syndrome	0.000981	0.0116	CbGeAlD
Asenapine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000951	0.0112	CbGeAlD
Asenapine—DRD4—brain—acquired immunodeficiency syndrome	0.000937	0.0111	CbGeAlD
Asenapine—HRH2—blood—acquired immunodeficiency syndrome	0.000935	0.011	CbGeAlD
Asenapine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000911	0.0107	CbGeAlD
Asenapine—DRD3—nervous system—acquired immunodeficiency syndrome	0.000862	0.0102	CbGeAlD
Asenapine—DRD3—central nervous system—acquired immunodeficiency syndrome	0.00083	0.00978	CbGeAlD
Asenapine—HTR6—nervous system—acquired immunodeficiency syndrome	0.00083	0.00978	CbGeAlD
Asenapine—HRH2—lung—acquired immunodeficiency syndrome	0.000819	0.00966	CbGeAlD
Asenapine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000809	0.00954	CbGeAlD
Asenapine—HTR1E—brain—acquired immunodeficiency syndrome	0.000808	0.00953	CbGeAlD
Asenapine—HTR6—central nervous system—acquired immunodeficiency syndrome	0.000799	0.00942	CbGeAlD
Asenapine—HRH2—nervous system—acquired immunodeficiency syndrome	0.000759	0.00894	CbGeAlD
Asenapine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000749	0.00883	CbGeAlD
Asenapine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000737	0.00869	CbGeAlD
Asenapine—HRH2—central nervous system—acquired immunodeficiency syndrome	0.00073	0.00861	CbGeAlD
Asenapine—HTR2B—skin of body—acquired immunodeficiency syndrome	0.000728	0.00858	CbGeAlD
Asenapine—DRD2—retina—acquired immunodeficiency syndrome	0.000672	0.00792	CbGeAlD
Asenapine—DRD3—brain—acquired immunodeficiency syndrome	0.000659	0.00777	CbGeAlD
Asenapine—HTR6—brain—acquired immunodeficiency syndrome	0.000634	0.00748	CbGeAlD
Asenapine—DRD1—nervous system—acquired immunodeficiency syndrome	0.000617	0.00728	CbGeAlD
Asenapine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000594	0.00701	CbGeAlD
Asenapine—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.000594	0.007	CbGeAlD
Asenapine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000588	0.00693	CbGeAlD
Asenapine—HTR2B—digestive system—acquired immunodeficiency syndrome	0.000582	0.00687	CbGeAlD
Asenapine—HRH2—brain—acquired immunodeficiency syndrome	0.00058	0.00684	CbGeAlD
Asenapine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000569	0.00671	CbGeAlD
Asenapine—HRH2—lymph node—acquired immunodeficiency syndrome	0.00056	0.00661	CbGeAlD
Asenapine—SLC6A4—blood—acquired immunodeficiency syndrome	0.00056	0.0066	CbGeAlD
Asenapine—HTR2B—blood—acquired immunodeficiency syndrome	0.000555	0.00654	CbGeAlD
Asenapine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000539	0.00636	CbGeAlD
Asenapine—HTR2B—vagina—acquired immunodeficiency syndrome	0.000514	0.00606	CbGeAlD
Asenapine—ADRB1—lung—acquired immunodeficiency syndrome	0.000508	0.00599	CbGeAlD
Asenapine—HTR1B—nervous system—acquired immunodeficiency syndrome	0.0005	0.0059	CbGeAlD
Asenapine—HTR7—digestive system—acquired immunodeficiency syndrome	0.000499	0.00588	CbGeAlD
Asenapine—SLC6A4—lung—acquired immunodeficiency syndrome	0.000491	0.00579	CbGeAlD
Asenapine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000487	0.00574	CbGeAlD
Asenapine—HTR2B—lung—acquired immunodeficiency syndrome	0.000486	0.00573	CbGeAlD
Asenapine—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000484	0.00571	CbGeAlD
Asenapine—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.000482	0.00568	CbGeAlD
Asenapine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.00048	0.00565	CbGeAlD
Asenapine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000479	0.00565	CbGeAlD
Asenapine—HTR7—blood—acquired immunodeficiency syndrome	0.000475	0.0056	CbGeAlD
Asenapine—DRD1—brain—acquired immunodeficiency syndrome	0.000472	0.00556	CbGeAlD
Asenapine—ADRB1—nervous system—acquired immunodeficiency syndrome	0.000471	0.00555	CbGeAlD
Asenapine—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000466	0.0055	CbGeAlD
Asenapine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000462	0.00544	CbGeAlD
Asenapine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000458	0.0054	CbGeAlD
Asenapine—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000458	0.0054	CbGeAlD
Asenapine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000455	0.00536	CbGeAlD
Asenapine—ADRB1—central nervous system—acquired immunodeficiency syndrome	0.000453	0.00534	CbGeAlD
Asenapine—HTR2B—nervous system—acquired immunodeficiency syndrome	0.00045	0.00531	CbGeAlD
Asenapine—HTR2A—retina—acquired immunodeficiency syndrome	0.000443	0.00522	CbGeAlD
Asenapine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000438	0.00516	CbGeAlD
Asenapine—ADRA2C—blood—acquired immunodeficiency syndrome	0.000437	0.00515	CbGeAlD
Asenapine—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.000434	0.00511	CbGeAlD
Asenapine—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000421	0.00496	CbGeAlD
Asenapine—HTR7—lung—acquired immunodeficiency syndrome	0.000417	0.00491	CbGeAlD
Asenapine—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000405	0.00477	CbGeAlD
Asenapine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000404	0.00476	CbGeAlD
Asenapine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000398	0.00469	CbGeAlD
Asenapine—DRD2—lung—acquired immunodeficiency syndrome	0.000394	0.00464	CbGeAlD
Asenapine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000389	0.00458	CbGeAlD
Asenapine—HTR7—nervous system—acquired immunodeficiency syndrome	0.000386	0.00455	CbGeAlD
Asenapine—ADRA2C—lung—acquired immunodeficiency syndrome	0.000383	0.00451	CbGeAlD
Asenapine—HTR1B—brain—acquired immunodeficiency syndrome	0.000382	0.00451	CbGeAlD
Asenapine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000379	0.00447	CbGeAlD
Asenapine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000372	0.00439	CbGeAlD
Asenapine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000372	0.00439	CbGeAlD
Asenapine—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000371	0.00438	CbGeAlD
Asenapine—HTR1D—brain—acquired immunodeficiency syndrome	0.00037	0.00436	CbGeAlD
Asenapine—HTR2C—brain—acquired immunodeficiency syndrome	0.000367	0.00432	CbGeAlD
Asenapine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000365	0.0043	CbGeAlD
Asenapine—ADRB1—brain—acquired immunodeficiency syndrome	0.00036	0.00424	CbGeAlD
Asenapine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000358	0.00422	CbGeAlD
Asenapine—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000355	0.00418	CbGeAlD
Asenapine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000351	0.00414	CbGeAlD
Asenapine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000348	0.00411	CbGeAlD
Asenapine—SLC6A4—brain—acquired immunodeficiency syndrome	0.000347	0.0041	CbGeAlD
Asenapine—HTR2B—brain—acquired immunodeficiency syndrome	0.000344	0.00406	CbGeAlD
Asenapine—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000341	0.00402	CbGeAlD
Asenapine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000336	0.00396	CbGeAlD
Asenapine—HTR2B—lymph node—acquired immunodeficiency syndrome	0.000333	0.00392	CbGeAlD
Asenapine—CYP1A2—lung—acquired immunodeficiency syndrome	0.000332	0.00392	CbGeAlD
Asenapine—HRH1—vagina—acquired immunodeficiency syndrome	0.000329	0.00388	CbGeAlD
Asenapine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000323	0.00381	CbGeAlD
Asenapine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000311	0.00367	CbGeAlD
Asenapine—HRH1—lung—acquired immunodeficiency syndrome	0.000311	0.00367	CbGeAlD
Asenapine—HTR1A—brain—acquired immunodeficiency syndrome	0.000309	0.00364	CbGeAlD
Asenapine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000305	0.0036	CbGeAlD
Asenapine—HTR2A—blood—acquired immunodeficiency syndrome	0.000296	0.00349	CbGeAlD
Asenapine—HTR7—brain—acquired immunodeficiency syndrome	0.000295	0.00348	CbGeAlD
Asenapine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000288	0.0034	CbGeAlD
Asenapine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000288	0.00339	CbGeAlD
Asenapine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000285	0.00337	CbGeAlD
Asenapine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000284	0.00335	CbGeAlD
Asenapine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000283	0.00334	CbGeAlD
Asenapine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000283	0.00334	CbGeAlD
Asenapine—DRD2—brain—acquired immunodeficiency syndrome	0.000279	0.00329	CbGeAlD
Asenapine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000277	0.00327	CbGeAlD
Asenapine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000275	0.00324	CbGeAlD
Asenapine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000274	0.00323	CbGeAlD
Asenapine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000272	0.00321	CbGeAlD
Asenapine—ADRA2C—brain—acquired immunodeficiency syndrome	0.000271	0.00319	CbGeAlD
Asenapine—CYP2D6—blood—acquired immunodeficiency syndrome	0.00027	0.00318	CbGeAlD
Asenapine—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.000947	CcSEcCtD
Asenapine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000264	0.000946	CcSEcCtD
Asenapine—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000262	0.00094	CcSEcCtD
Asenapine—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000262	0.00309	CbGeAlD
Asenapine—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.000937	CcSEcCtD
Asenapine—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.000934	CcSEcCtD
Asenapine—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.000933	CcSEcCtD
Asenapine—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.000933	CcSEcCtD
Asenapine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00026	0.000932	CcSEcCtD
Asenapine—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.000931	CcSEcCtD
Asenapine—HTR2A—lung—acquired immunodeficiency syndrome	0.00026	0.00306	CbGeAlD
Asenapine—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.00026	0.00093	CcSEcCtD
Asenapine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.000928	CcSEcCtD
Asenapine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.000928	CcSEcCtD
Asenapine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000258	0.000923	CcSEcCtD
Asenapine—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.000915	CcSEcCtD
Asenapine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000255	0.000915	CcSEcCtD
Asenapine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000255	0.000912	CcSEcCtD
Asenapine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000254	0.000911	CcSEcCtD
Asenapine—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000254	0.000911	CcSEcCtD
Asenapine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000253	0.000906	CcSEcCtD
Asenapine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000253	0.000906	CcSEcCtD
Asenapine—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000253	0.000905	CcSEcCtD
Asenapine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000252	0.000904	CcSEcCtD
Asenapine—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.000899	CcSEcCtD
Asenapine—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000251	0.000899	CcSEcCtD
Asenapine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000251	0.000899	CcSEcCtD
Asenapine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000251	0.000898	CcSEcCtD
Asenapine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000251	0.000898	CcSEcCtD
Asenapine—Shock—Indinavir—acquired immunodeficiency syndrome	0.00025	0.000897	CcSEcCtD
Asenapine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00025	0.000896	CcSEcCtD
Asenapine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00025	0.000894	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000249	0.000893	CcSEcCtD
Asenapine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000249	0.000893	CcSEcCtD
Asenapine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000249	0.000893	CcSEcCtD
Asenapine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00089	CcSEcCtD
Asenapine—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.000888	CcSEcCtD
Asenapine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.000888	CcSEcCtD
Asenapine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000248	0.000887	CcSEcCtD
Asenapine—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000246	0.00088	CcSEcCtD
Asenapine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000245	0.000879	CcSEcCtD
Asenapine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000244	0.000875	CcSEcCtD
Asenapine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000244	0.000874	CcSEcCtD
Asenapine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.000872	CcSEcCtD
Asenapine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000243	0.000872	CcSEcCtD
Asenapine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.000864	CcSEcCtD
Asenapine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.000863	CcSEcCtD
Asenapine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000241	0.000863	CcSEcCtD
Asenapine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000241	0.00284	CbGeAlD
Asenapine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00024	0.000861	CcSEcCtD
Asenapine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00024	0.00086	CcSEcCtD
Asenapine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.000858	CcSEcCtD
Asenapine—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.000858	CcSEcCtD
Asenapine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.000857	CcSEcCtD
Asenapine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000237	0.000848	CcSEcCtD
Asenapine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000236	0.000847	CcSEcCtD
Asenapine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.000846	CcSEcCtD
Asenapine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.000845	CcSEcCtD
Asenapine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.000845	CcSEcCtD
Asenapine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.000843	CcSEcCtD
Asenapine—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000235	0.000842	CcSEcCtD
Asenapine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.000842	CcSEcCtD
Asenapine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.000841	CcSEcCtD
Asenapine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.000841	CcSEcCtD
Asenapine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.00084	CcSEcCtD
Asenapine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000234	0.000838	CcSEcCtD
Asenapine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000234	0.000838	CcSEcCtD
Asenapine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.000838	CcSEcCtD
Asenapine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000836	CcSEcCtD
Asenapine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000233	0.000834	CcSEcCtD
Asenapine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000232	0.000831	CcSEcCtD
Asenapine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000831	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000232	0.000831	CcSEcCtD
Asenapine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000232	0.00273	CbGeAlD
Asenapine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000231	0.000826	CcSEcCtD
Asenapine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.000826	CcSEcCtD
Asenapine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00023	0.000825	CcSEcCtD
Asenapine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.000824	CcSEcCtD
Asenapine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.000821	CcSEcCtD
Asenapine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000229	0.000819	CcSEcCtD
Asenapine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000229	0.000819	CcSEcCtD
Asenapine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000228	0.000818	CcSEcCtD
Asenapine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000227	0.000814	CcSEcCtD
Asenapine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000227	0.000813	CcSEcCtD
Asenapine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000227	0.000812	CcSEcCtD
Asenapine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.000811	CcSEcCtD
Asenapine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000226	0.000811	CcSEcCtD
Asenapine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000226	0.000811	CcSEcCtD
Asenapine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000226	0.000809	CcSEcCtD
Asenapine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000809	CcSEcCtD
Asenapine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.000807	CcSEcCtD
Asenapine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.000806	CcSEcCtD
Asenapine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.000806	CcSEcCtD
Asenapine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.000805	CcSEcCtD
Asenapine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.000804	CcSEcCtD
Asenapine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000224	0.000803	CcSEcCtD
Asenapine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000224	0.000803	CcSEcCtD
Asenapine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000223	0.00263	CbGeAlD
Asenapine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000223	0.000797	CcSEcCtD
Asenapine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.000795	CcSEcCtD
Asenapine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.000793	CcSEcCtD
Asenapine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.000792	CcSEcCtD
Asenapine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00079	CcSEcCtD
Asenapine—HRH1—brain—acquired immunodeficiency syndrome	0.00022	0.0026	CbGeAlD
Asenapine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00022	0.000787	CcSEcCtD
Asenapine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000219	0.000786	CcSEcCtD
Asenapine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000219	0.00258	CbGeAlD
Asenapine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000219	0.000785	CcSEcCtD
Asenapine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.000784	CcSEcCtD
Asenapine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000218	0.00078	CcSEcCtD
Asenapine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000218	0.000779	CcSEcCtD
Asenapine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.000779	CcSEcCtD
Asenapine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.000778	CcSEcCtD
Asenapine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.000776	CcSEcCtD
Asenapine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000216	0.00255	CbGeAlD
Asenapine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.000773	CcSEcCtD
Asenapine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000215	0.000772	CcSEcCtD
Asenapine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.00077	CcSEcCtD
Asenapine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.000769	CcSEcCtD
Asenapine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000214	0.000768	CcSEcCtD
Asenapine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000214	0.00253	CbGeAlD
Asenapine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000768	CcSEcCtD
Asenapine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000214	0.000766	CcSEcCtD
Asenapine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.000765	CcSEcCtD
Asenapine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000763	CcSEcCtD
Asenapine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000213	0.00251	CbGeAlD
Asenapine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.000758	CcSEcCtD
Asenapine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000211	0.00249	CbGeAlD
Asenapine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.000754	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.000751	CcSEcCtD
Asenapine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00075	CcSEcCtD
Asenapine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.000748	CcSEcCtD
Asenapine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000209	0.00246	CbGeAlD
Asenapine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000209	0.000748	CcSEcCtD
Asenapine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.000747	CcSEcCtD
Asenapine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000746	CcSEcCtD
Asenapine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000208	0.000746	CcSEcCtD
Asenapine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000745	CcSEcCtD
Asenapine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000744	CcSEcCtD
Asenapine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000744	CcSEcCtD
Asenapine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000743	CcSEcCtD
Asenapine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000207	0.000743	CcSEcCtD
Asenapine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.000743	CcSEcCtD
Asenapine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000737	CcSEcCtD
Asenapine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000206	0.000737	CcSEcCtD
Asenapine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000205	0.000736	CcSEcCtD
Asenapine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000205	0.000735	CcSEcCtD
Asenapine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000205	0.000735	CcSEcCtD
Asenapine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000205	0.000733	CcSEcCtD
Asenapine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000204	0.000732	CcSEcCtD
Asenapine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.00073	CcSEcCtD
Asenapine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000728	CcSEcCtD
Asenapine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.000726	CcSEcCtD
Asenapine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000722	CcSEcCtD
Asenapine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000719	CcSEcCtD
Asenapine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000201	0.000719	CcSEcCtD
Asenapine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000718	CcSEcCtD
Asenapine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.0002	0.000717	CcSEcCtD
Asenapine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000714	CcSEcCtD
Asenapine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000199	0.000713	CcSEcCtD
Asenapine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000199	0.000713	CcSEcCtD
Asenapine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000712	CcSEcCtD
Asenapine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000712	CcSEcCtD
Asenapine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000199	0.000711	CcSEcCtD
Asenapine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.000711	CcSEcCtD
Asenapine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000198	0.000711	CcSEcCtD
Asenapine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000198	0.000709	CcSEcCtD
Asenapine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000197	0.000707	CcSEcCtD
Asenapine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000197	0.000707	CcSEcCtD
Asenapine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000705	CcSEcCtD
Asenapine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000196	0.000703	CcSEcCtD
Asenapine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000196	0.000701	CcSEcCtD
Asenapine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000195	0.0007	CcSEcCtD
Asenapine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.0007	CcSEcCtD
Asenapine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000194	0.000696	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000694	CcSEcCtD
Asenapine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000194	0.000694	CcSEcCtD
Asenapine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000689	CcSEcCtD
Asenapine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000689	CcSEcCtD
Asenapine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000686	CcSEcCtD
Asenapine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000686	CcSEcCtD
Asenapine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000685	CcSEcCtD
Asenapine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.00068	CcSEcCtD
Asenapine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000678	CcSEcCtD
Asenapine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000188	0.000672	CcSEcCtD
Asenapine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000188	0.000672	CcSEcCtD
Asenapine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000671	CcSEcCtD
Asenapine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000187	0.00067	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000668	CcSEcCtD
Asenapine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000664	CcSEcCtD
Asenapine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000184	0.00066	CcSEcCtD
Asenapine—HTR2A—brain—acquired immunodeficiency syndrome	0.000184	0.00217	CbGeAlD
Asenapine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000658	CcSEcCtD
Asenapine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.000657	CcSEcCtD
Asenapine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000183	0.000654	CcSEcCtD
Asenapine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000654	CcSEcCtD
Asenapine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000654	CcSEcCtD
Asenapine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000652	CcSEcCtD
Asenapine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000652	CcSEcCtD
Asenapine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000181	0.000648	CcSEcCtD
Asenapine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000646	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000638	CcSEcCtD
Asenapine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.000635	CcSEcCtD
Asenapine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000633	CcSEcCtD
Asenapine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000633	CcSEcCtD
Asenapine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000632	CcSEcCtD
Asenapine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000627	CcSEcCtD
Asenapine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000624	CcSEcCtD
Asenapine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.000623	CcSEcCtD
Asenapine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000622	CcSEcCtD
Asenapine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000173	0.000618	CcSEcCtD
Asenapine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000173	0.000618	CcSEcCtD
Asenapine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000172	0.000618	CcSEcCtD
Asenapine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000616	CcSEcCtD
Asenapine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.000614	CcSEcCtD
Asenapine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.000607	CcSEcCtD
Asenapine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000604	CcSEcCtD
Asenapine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000603	CcSEcCtD
Asenapine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000168	0.000603	CcSEcCtD
Asenapine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000167	0.00197	CbGeAlD
Asenapine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000598	CcSEcCtD
Asenapine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.000591	CcSEcCtD
Asenapine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000163	0.000582	CcSEcCtD
Asenapine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000162	0.00058	CcSEcCtD
Asenapine—Rash—Indinavir—acquired immunodeficiency syndrome	0.00016	0.000575	CcSEcCtD
Asenapine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00016	0.000574	CcSEcCtD
Asenapine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000159	0.000571	CcSEcCtD
Asenapine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.00057	CcSEcCtD
Asenapine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000562	CcSEcCtD
Asenapine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000548	CcSEcCtD
Asenapine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000547	CcSEcCtD
Asenapine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000545	CcSEcCtD
Asenapine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000543	CcSEcCtD
Asenapine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000543	CcSEcCtD
Asenapine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000542	CcSEcCtD
Asenapine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.00054	CcSEcCtD
Asenapine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.00054	CcSEcCtD
Asenapine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000526	CcSEcCtD
Asenapine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000524	CcSEcCtD
Asenapine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.00052	CcSEcCtD
Asenapine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000519	CcSEcCtD
Asenapine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000516	CcSEcCtD
Asenapine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000516	CcSEcCtD
Asenapine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000512	CcSEcCtD
Asenapine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000504	CcSEcCtD
Asenapine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000502	CcSEcCtD
Asenapine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.00049	CcSEcCtD
Asenapine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000485	CcSEcCtD
Asenapine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000485	CcSEcCtD
Asenapine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000481	CcSEcCtD
Asenapine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.00048	CcSEcCtD
Asenapine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000477	CcSEcCtD
Asenapine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000466	CcSEcCtD
Asenapine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000463	CcSEcCtD
Asenapine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000463	CcSEcCtD
Asenapine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000462	CcSEcCtD
Asenapine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.00046	CcSEcCtD
Asenapine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000453	CcSEcCtD
Asenapine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000445	CcSEcCtD
Asenapine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000441	CcSEcCtD
Asenapine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000441	CcSEcCtD
Asenapine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000438	CcSEcCtD
Asenapine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000436	CcSEcCtD
Asenapine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000416	CcSEcCtD
Asenapine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.2e-05	0.000224	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.2e-05	0.000224	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.2e-05	0.000224	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.19e-05	0.000223	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.17e-05	0.000221	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.16e-05	0.00022	CbGpPWpGaD
Asenapine—HRH2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.16e-05	0.00022	CbGpPWpGaD
Asenapine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.15e-05	0.000219	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.15e-05	0.000219	CbGpPWpGaD
Asenapine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.15e-05	0.000218	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.14e-05	0.000218	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.13e-05	0.000216	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.13e-05	0.000216	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.12e-05	0.000216	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.11e-05	0.000215	CbGpPWpGaD
Asenapine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.11e-05	0.000214	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.1e-05	0.000213	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.1e-05	0.000213	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.08e-05	0.000212	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	2.07e-05	0.000211	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.07e-05	0.00021	CbGpPWpGaD
Asenapine—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	2.07e-05	0.00021	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.05e-05	0.000209	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.05e-05	0.000209	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.05e-05	0.000209	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.04e-05	0.000207	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.04e-05	0.000207	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.03e-05	0.000207	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.03e-05	0.000207	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.03e-05	0.000207	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.02e-05	0.000205	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.02e-05	0.000205	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.01e-05	0.000205	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.01e-05	0.000204	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2e-05	0.000204	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2e-05	0.000203	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.99e-05	0.000203	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.99e-05	0.000202	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.98e-05	0.000201	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.96e-05	0.0002	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.95e-05	0.000198	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.94e-05	0.000197	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.91e-05	0.000194	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.91e-05	0.000194	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.89e-05	0.000193	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.89e-05	0.000193	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.89e-05	0.000192	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.88e-05	0.000191	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.88e-05	0.000191	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.88e-05	0.000191	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.87e-05	0.00019	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.87e-05	0.00019	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.87e-05	0.00019	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.86e-05	0.00019	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.86e-05	0.000189	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.85e-05	0.000189	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.85e-05	0.000188	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.85e-05	0.000188	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.85e-05	0.000188	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.84e-05	0.000187	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.84e-05	0.000187	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.83e-05	0.000186	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.83e-05	0.000186	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.83e-05	0.000186	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.83e-05	0.000186	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.83e-05	0.000186	CbGpPWpGaD
Asenapine—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.82e-05	0.000186	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.82e-05	0.000185	CbGpPWpGaD
Asenapine—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.82e-05	0.000185	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.82e-05	0.000185	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.82e-05	0.000185	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.82e-05	0.000185	CbGpPWpGaD
Asenapine—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.81e-05	0.000184	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.8e-05	0.000183	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.8e-05	0.000183	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.8e-05	0.000183	CbGpPWpGaD
Asenapine—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.77e-05	0.00018	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.77e-05	0.00018	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.77e-05	0.00018	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.77e-05	0.00018	CbGpPWpGaD
Asenapine—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.74e-05	0.000177	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.74e-05	0.000177	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.72e-05	0.000175	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.71e-05	0.000174	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.69e-05	0.000172	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.69e-05	0.000172	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.69e-05	0.000172	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.69e-05	0.000172	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.68e-05	0.000171	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.68e-05	0.000171	CbGpPWpGaD
Asenapine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.68e-05	0.000171	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.68e-05	0.000171	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.67e-05	0.00017	CbGpPWpGaD
Asenapine—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.66e-05	0.000169	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.66e-05	0.000168	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.65e-05	0.000168	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.65e-05	0.000167	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.65e-05	0.000167	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.64e-05	0.000167	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.62e-05	0.000165	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.62e-05	0.000165	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.61e-05	0.000164	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.61e-05	0.000163	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.61e-05	0.000163	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.6e-05	0.000162	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.59e-05	0.000162	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.58e-05	0.000161	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.58e-05	0.000161	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.58e-05	0.000161	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.58e-05	0.00016	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.58e-05	0.00016	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.57e-05	0.00016	CbGpPWpGaD
Asenapine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.57e-05	0.00016	CbGpPWpGaD
Asenapine—HTR5A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.56e-05	0.000159	CbGpPWpGaD
Asenapine—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.55e-05	0.000158	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.55e-05	0.000157	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.55e-05	0.000157	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.55e-05	0.000157	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.53e-05	0.000156	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.51e-05	0.000154	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.46e-05	0.000148	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.45e-05	0.000148	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.44e-05	0.000147	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.44e-05	0.000146	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.44e-05	0.000146	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.44e-05	0.000146	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.43e-05	0.000146	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000146	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000145	CbGpPWpGaD
Asenapine—HTR1E—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.43e-05	0.000145	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.42e-05	0.000145	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.42e-05	0.000144	CbGpPWpGaD
Asenapine—ADRB1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.41e-05	0.000144	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.41e-05	0.000143	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.4e-05	0.000143	CbGpPWpGaD
Asenapine—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.4e-05	0.000142	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.39e-05	0.000142	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.38e-05	0.000141	CbGpPWpGaD
Asenapine—ADRB2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.38e-05	0.00014	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.37e-05	0.000139	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.36e-05	0.000139	CbGpPWpGaD
Asenapine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.35e-05	0.000137	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.35e-05	0.000137	CbGpPWpGaD
Asenapine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.34e-05	0.000137	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.33e-05	0.000135	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.31e-05	0.000133	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.31e-05	0.000133	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.3e-05	0.000132	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.28e-05	0.00013	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.28e-05	0.00013	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.28e-05	0.00013	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.27e-05	0.000129	CbGpPWpGaD
Asenapine—HRH2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.27e-05	0.000129	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.25e-05	0.000128	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.25e-05	0.000128	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.25e-05	0.000127	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.23e-05	0.000125	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.22e-05	0.000124	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.22e-05	0.000124	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.21e-05	0.000123	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.2e-05	0.000122	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.2e-05	0.000122	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.2e-05	0.000122	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.19e-05	0.000121	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.19e-05	0.000121	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.18e-05	0.00012	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.18e-05	0.00012	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.18e-05	0.00012	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.17e-05	0.000119	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.16e-05	0.000118	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.16e-05	0.000118	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.14e-05	0.000116	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.1e-05	0.000112	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.09e-05	0.000111	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.08e-05	0.00011	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.08e-05	0.00011	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.08e-05	0.00011	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.08e-05	0.000109	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.06e-05	0.000108	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.06e-05	0.000108	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.06e-05	0.000108	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.06e-05	0.000108	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.04e-05	0.000106	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.04e-05	0.000105	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	1.03e-05	0.000105	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.85e-06	0.0001	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.79e-06	9.95e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.77e-06	9.94e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.74e-06	9.9e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.73e-06	9.89e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.71e-06	9.88e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.66e-06	9.83e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.64e-06	9.8e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.51e-06	9.67e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.46e-06	9.62e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.36e-06	9.52e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.31e-06	9.47e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.93e-06	9.08e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.89e-06	9.04e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.42e-06	8.57e-05	CbGpPWpGaD
Asenapine—HTR1E—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.42e-06	8.56e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	8.4e-06	8.54e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.38e-06	8.52e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.31e-06	8.45e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.27e-06	8.41e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.57e-06	7.7e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.53e-06	7.66e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.5e-06	7.63e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.5e-06	7.63e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.47e-06	7.59e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.41e-06	7.53e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.37e-06	7.5e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.24e-06	7.37e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.21e-06	7.33e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.21e-06	7.33e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.17e-06	7.29e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.01e-06	7.13e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.97e-06	7.09e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.36e-06	6.47e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.33e-06	6.44e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.26e-06	6.36e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.24e-06	6.35e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.23e-06	6.33e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.21e-06	6.32e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.13e-06	6.23e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.1e-06	6.2e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.75e-06	5.85e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.75e-06	5.84e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.71e-06	5.81e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.69e-06	5.79e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.66e-06	5.76e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.59e-06	5.68e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.5e-06	5.59e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	5.47e-06	5.56e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.25e-06	5.34e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.95e-06	5.04e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.88e-06	4.97e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	4.63e-06	4.71e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.45e-06	4.53e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.41e-06	4.49e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.35e-06	4.43e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.26e-06	4.33e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.24e-06	4.31e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.12e-06	4.19e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.74e-06	3.8e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.68e-06	3.74e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.67e-06	3.73e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.6e-06	3.66e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	3.58e-06	3.64e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.35e-06	3.4e-05	CbGpPWpGaD
